Trade Summary

3 days ago, Sauvage Philippe, serving as Chief Financial Officer at Nuvation Bio Inc. (NUVB), sold 47,668 shares at $6.01 per share, for a total transaction value of $286,370.28. Following this transaction, Sauvage Philippe now holds 12,673 shares of NUVB.

This sale represents a 79.00% decrease in Sauvage Philippe's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 7:07 PM ET, 1 day after the trade was made.

Nuvation Bio Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.